Literature DB >> 24721653

Recent genetic discoveries implicating ion channels in human cardiovascular diseases.

Alfred L George1.   

Abstract

The term 'channelopathy' refers to human genetic disorders caused by mutations in genes encoding ion channels or their interacting proteins. Recent advances in this field have been enabled by next-generation DNA sequencing strategies such as whole exome sequencing with several intriguing and unexpected discoveries. This review highlights important discoveries implicating ion channels or ion channel modulators in cardiovascular disorders including cardiac arrhythmia susceptibility, cardiac conduction phenotypes, pulmonary and systemic hypertension. These recent discoveries further emphasize the importance of ion channels in the pathophysiology of human disease and as important druggable targets.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24721653      PMCID: PMC3984451          DOI: 10.1016/j.coph.2013.11.011

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  50 in total

1.  A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.

Authors:  Dan E Arking; Arne Pfeufer; Wendy Post; W H Linda Kao; Christopher Newton-Cheh; Morna Ikeda; Kristen West; Carl Kashuk; Mahmut Akyol; Siegfried Perz; Shapour Jalilzadeh; Thomas Illig; Christian Gieger; Chao-Yu Guo; Martin G Larson; H Erich Wichmann; Eduardo Marbán; Christopher J O'Donnell; Joel N Hirschhorn; Stefan Kääb; Peter M Spooner; Thomas Meitinger; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2006-04-30       Impact factor: 38.330

2.  Impact of TASK-1 in human pulmonary artery smooth muscle cells.

Authors:  Andrea Olschewski; Yingji Li; Bi Tang; Jörg Hanze; Bastian Eul; Rainer M Bohle; Jochen Wilhelm; Rory E Morty; Michael E Brau; E Kenneth Weir; Grazyna Kwapiszewska; Walter Klepetko; Werner Seeger; Horst Olschewski
Journal:  Circ Res       Date:  2006-03-30       Impact factor: 17.367

Review 3.  The role of twin pore domain and other K+ channels in hypoxic pulmonary vasoconstriction.

Authors:  Alison M Gurney; Shreena Joshi
Journal:  Novartis Found Symp       Date:  2006

4.  Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation.

Authors:  Jessica T Delaney; Raafia Muhammad; Yaping Shi; Jonathan S Schildcrout; Marcia Blair; Laura Short; Dan M Roden; Dawood Darbar
Journal:  Europace       Date:  2013-09-26       Impact factor: 5.214

5.  Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts.

Authors:  R Brugada; J Brugada; C Antzelevitch; G E Kirsch; D Potenza; J A Towbin; P Brugada
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

6.  Recombinase-mediated cassette exchange to rapidly and efficiently generate mice with human cardiac sodium channels.

Authors:  Kai Liu; Susan Hipkens; Tao Yang; Robert Abraham; Wei Zhang; Nagesh Chopra; Bjorn Knollmann; Mark A Magnuson; Dan M Roden
Journal:  Genesis       Date:  2006-11       Impact factor: 2.487

7.  A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.

Authors:  Dagmar I Keller; Hai Huang; Juan Zhao; Rudolf Frank; Vivian Suarez; Etienne Delacrétaz; Marijke Brink; Stefan Osswald; Nicola Schwick; Mohamed Chahine
Journal:  Cardiovasc Res       Date:  2006-03-03       Impact factor: 10.787

8.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study.

Authors:  Arne Pfeufer; Serena Sanna; Dan E Arking; Martina Müller; Vesela Gateva; Christian Fuchsberger; Georg B Ehret; Marco Orrú; Cristian Pattaro; Anna Köttgen; Siegfried Perz; Gianluca Usala; Maja Barbalic; Man Li; Benno Pütz; Angelo Scuteri; Ronald J Prineas; Moritz F Sinner; Christian Gieger; Samer S Najjar; W H Linda Kao; Thomas W Mühleisen; Mariano Dei; Christine Happle; Stefan Möhlenkamp; Laura Crisponi; Raimund Erbel; Karl-Heinz Jöckel; Silvia Naitza; Gerhard Steinbeck; Fabio Marroni; Andrew A Hicks; Edward Lakatta; Bertram Müller-Myhsok; Peter P Pramstaller; H-Erich Wichmann; David Schlessinger; Eric Boerwinkle; Thomas Meitinger; Manuela Uda; Josef Coresh; Stefan Kääb; Gonçalo R Abecasis; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2009-03-22       Impact factor: 38.330

9.  Targeted capture and massively parallel sequencing of 12 human exomes.

Authors:  Sarah B Ng; Emily H Turner; Peggy D Robertson; Steven D Flygare; Abigail W Bigham; Choli Lee; Tristan Shaffer; Michelle Wong; Arindam Bhattacharjee; Evan E Eichler; Michael Bamshad; Deborah A Nickerson; Jay Shendure
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

10.  Common variants at ten loci influence QT interval duration in the QTGEN Study.

Authors:  Christopher Newton-Cheh; Mark Eijgelsheim; Kenneth M Rice; Paul I W de Bakker; Xiaoyan Yin; Karol Estrada; Joshua C Bis; Kristin Marciante; Fernando Rivadeneira; Peter A Noseworthy; Nona Sotoodehnia; Nicholas L Smith; Jerome I Rotter; Jan A Kors; Jacqueline C M Witteman; Albert Hofman; Susan R Heckbert; Christopher J O'Donnell; André G Uitterlinden; Bruce M Psaty; Thomas Lumley; Martin G Larson; Bruno H Ch Stricker
Journal:  Nat Genet       Date:  2009-03-22       Impact factor: 38.330

View more
  4 in total

Review 1.  Genetically engineered livestock for biomedical models.

Authors:  Christopher S Rogers
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 2.  Pharmacogenomics of cardiovascular complications in diabetes and obesity.

Authors:  Kalyan Chapalamadugu; Siva K Panguluri; Aimon Miranda; Kevin B Sneed; Srinivas M Tipparaju
Journal:  Recent Pat Biotechnol       Date:  2014

Review 3.  Sulfur-containing gaseous signal molecules, ion channels and cardiovascular diseases.

Authors:  Wen Yu; Hongfang Jin; Chaoshu Tang; Junbao Du; Zhiren Zhang
Journal:  Br J Pharmacol       Date:  2017-05-30       Impact factor: 8.739

4.  Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines.

Authors:  A Chhibber; C E French; S W Yee; E R Gamazon; E Theusch; X Qin; A Webb; A C Papp; A Wang; C Q Simmons; A Konkashbaev; A S Chaudhry; K Mitchel; D Stryke; T E Ferrin; S T Weiss; D L Kroetz; W Sadee; D A Nickerson; R M Krauss; A L George; E G Schuetz; M W Medina; N J Cox; S E Scherer; K M Giacomini; S E Brenner
Journal:  Pharmacogenomics J       Date:  2016-02-09       Impact factor: 3.550

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.